<DOC>
	<DOCNO>NCT00960245</DOCNO>
	<brief_summary>The purpose study demonstrate relative bioavailability Nadolol ( 1 x 80 mg ) tablet fast condition .</brief_summary>
	<brief_title>Relative Bioavailability Study Nadolol ( 1 x 80 mg ) Tablets Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Chest Pain</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nadolol</mesh_term>
	<criteria>No clinically significant abnormal find physical exam , medical history , clinical laboratory result screen . Positive test result HIV hepatitis B C. Treatment drug alcohol dependence .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>